Actinium Pharmaceuticals Appoints Radiopharmaceutical Industry Veteran Sean Maenpaa as Senior Vice President, Business Development

Positive

AI Analysis

Summary

Actinium Pharmaceuticals appointed radiopharmaceutical industry veteran Sean Maenpaa as Senior Vice President, Business Development. He brings over 20 years of oncology business development and commercial experience, including roles at Bayer, Clovis Oncology, Telix Pharmaceuticals and BWXT Medical, and will lead partnering, licensing and strategic transactions.

Outcome Details

Appointment of Sean Maenpaa as Senior Vice President, Business Development, to lead partnering, licensing and strategic transactions

Importance:5/10

Sentiment:

0.30

management changeexecutive appointmentbusiness developmentradiopharmaceuticaloncology

Related Companies

$BAYRY $CLVS $TLPPF

Read the original article

Published by PR Newswire Biotech on October 16, 2026 11:30 AM

Read Original